Order reprints

Open Access

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease

Gemma Bruera, Katia Cannita, Daniela Di Giacomo, Aude Lamy, Giancarlo Troncone, Antonella Dal Mas, Gino Coletti, Thierry Frébourg, Jean Christophe Sabourin, Mario Tosi, Corrado Ficorella and Enrico Ricevuto*

BMC Medicine 2012, 10:135  doi:10.1186/1741-7015-10-135

This article is currently available as a provisional PDF. Reprints are produced from the final PDF, which is normally produced within 3 weeks.

Please complete the following form to register your interest in ordering reprints of this article. BioMed Central will contact you by email when the final PDF is available with details of how to obtain a quotation and place an order.

Fields marked * are required

http://www.biomedcentral.com/1741-7015/10/135
1741-7015-10-135